Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01950871 | Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning(PHSTT-01) | terminated | Phase 4 | 80 | Advanced Medical Diagnostics s.a.INDUSTRY | 18 | Jan 5, 2015 | clinicaltrials |
| NCT01365143 | Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy | terminated | Phase 4 | 10 | Mayo ClinicOTHER | 1 | Jun 2, 2014 | clinicaltrials |
| NCT00805701 | Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation | completed | Phase 4 | 40 | Bay State Clinical Trials, Inc.OTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT01486563 | Hydroxyethyl Starch and Renal Function After Radical Prostatectomy(VORA) | completed | Phase 4 | 40 | Regional Hospital HolstebroOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01161563 | Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration | completed | Phase 4 | 118 | Watson PharmaceuticalsINDUSTRY | 1 | Sep 6, 2013 | clinicaltrials |
| NCT01547416 | The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function | completed | Phase 4 | 50 | Yonsei UniversityOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01379742 | Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy | unknown | Phase 4 | 240 | Prostate Cancer Foundation of ChicagoOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00771966 | Radical Prostatectomy and Perioperative Fluid Therapy | completed | Phase 4 | 44 | Rigshospitalet, DenmarkOTHER | 1 | Oct 22, 2012 | clinicaltrials |
| NCT00029224 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | completed | Phase 4 | 500 | NovartisINDUSTRY | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00526331 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | completed | Phase 4 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00106392 | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy | completed | Phase 4 | 131 | Astellas Pharma IncINDUSTRY | 1 | Nov 23, 2010 | clinicaltrials |
| NCT00982800 | Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy? | completed | Phase 4 | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Aug 6, 2010 | clinicaltrials |
| NCT00422708 | Local Anesthesia for Prostate Biopsy | completed | Phase 4 | 243 | Mayo ClinicOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00280098 | Docetaxel in the Treatment of Hormone Refractory Prostate Cancer | completed | Phase 4 | 30 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00035997 | Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00199485 | Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer | completed | Phase 4 | 44 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 29, 2008 | clinicaltrials |
| NCT00590213 | Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX(COMART) | completed | Phase 4 | 125 | AstraZenecaINDUSTRY | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00255268 | CMAB vs IMAB in Metastatic Prostate Cancer | withdrawn | Phase 4 | 15 | AstraZenecaINDUSTRY | 1 | Aug 28, 2007 | clinicaltrials |
| NCT00293696 | Casodex/Zoladex Biomarkers in Localised Prostate Cancer | completed | Phase 4 | 30 | Tampere UniversityOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00103623 | The Plenaxis® Experience Study | suspended | Phase 4 | 2,000 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00185029 | MR-Lymphography and Lymph Node Staging in Prostate Cancer | unknown | Phase 4 | 396 | Radboud University Medical CenterOTHER | 1 | Sep 16, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jan 5, 2015source: clinicaltrials